Factors associated with anemia in patients with cancer admitted to an intensive care unit

Cardenas‐Turanzas, Marylou; Cesta, Mark; Wakefield, Chris; Wallace, Susannah Kish; Puana, Rudolph; Price, Kristen; Nates, Joseph L.

doi:10.1016/j.jcrc.2009.02.004

Cited by 6 publications

(7 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several factors are associated with the prevalence of anemia in cancer patients. The most common factors include demographic factors [ 9 ], biological factors [ 10 ], chemotherapy [ 11 ], and types of cancer [ 9 ]. Socio-demographic factors including increasing age [ 9 , 12 ]; race, for example, Hispanics [ 9 ]; and gender, for example, women, played a significant role in the incidence of anemia in cancer patients.…”

Section: Introductionmentioning

confidence: 99%

“…The most common factors include demographic factors [ 9 ], biological factors [ 10 ], chemotherapy [ 11 ], and types of cancer [ 9 ]. Socio-demographic factors including increasing age [ 9 , 12 ]; race, for example, Hispanics [ 9 ]; and gender, for example, women, played a significant role in the incidence of anemia in cancer patients. In addition, number of chemotherapy regimens [ 13 , 14 ], type of chemotherapy [ 9 , 13 ], and chemotherapy dose delay or dose reduction [ 15 ] all increased incidence of cancer related anemia (CRA).…”

Section: Introductionmentioning

confidence: 99%

“…Socio-demographic factors including increasing age [ 9 , 12 ]; race, for example, Hispanics [ 9 ]; and gender, for example, women, played a significant role in the incidence of anemia in cancer patients. In addition, number of chemotherapy regimens [ 13 , 14 ], type of chemotherapy [ 9 , 13 ], and chemotherapy dose delay or dose reduction [ 15 ] all increased incidence of cancer related anemia (CRA). Moreover, cancer itself [ 13 , 16 ] and type of cancer [ 16 , 17 ] are associated significantly with anemia among cancer patients.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Prevalence and Associated Factors of Anemia among Breast Cancer Patients Undergoing Chemotherapy: A Prospective Study

Muthanna

Karuppannan

Abdulrahman

et al. 2022

Advances in Pharmacological and Pharmaceutical Sciences

View full text Add to dashboard Cite

Purpose. The purpose of this study was to ascertain the prevalence and factors associated with anemia (hemoglobin [Hb] 12 g/dL) in breast cancer patients undergoing chemotherapy. Materials and Methods. We conducted a prospective longitudinal study to collect demographic and clinical data on adult breast cancer patients with or without anemia who were admitted to HKL, UMMC, and NCI. The incidence of anemia was determined by detecting whether or not anemia developed during the course of chemotherapy. Mild, moderate, or severe anemia was defined. A chi-squared and logistic regression model were used to assess the effect of demographic and clinical factors on the incidence of anemia and multiple logistic regression analysis was used to evaluate the associations of potential risk factors with the presence of CRA. Results. The study enrolled a total of 292 breast cancer patients. Anemia occurred at a rate of 41.1% (n = 120). Our findings indicated that clinical factors such as the number of chemotherapy regimens, dose reduction, and type of chemotherapy, for example, docetaxel, as well as demographic covariates such as age and BMI, all contribute to the incidence of anemia in cancer patients. Conclusions. According to this study, the prevalence of anemia in breast cancer patients is high. Patients' age, BMI, number of chemotherapy regimens, and docetaxel were risk factors; thus, protocols are needed to identify subgroups of breast cancer likely to benefit from novel management strategies.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Prevalence and Associated Factors of Anemia among Breast Cancer Patients Undergoing Chemotherapy: A Prospective Study

Muthanna

Karuppannan

Abdulrahman

et al. 2022

Advances in Pharmacological and Pharmaceutical Sciences

View full text Add to dashboard Cite

show abstract

“…Several factors are associated with the prevalence of anemia in cancer patients. The most common factors include demographic factors (9), biological factors (10), chemotherapy (11), and types of cancer (9). Socio-demographic factors including increasing age (12,9), race e.g., Hispanics (9) and gender e.g., women, played a signi cant role in the incidence of anemia in cancer patients.…”

Section: Introductionmentioning

confidence: 99%

“…The most common factors include demographic factors (9), biological factors (10), chemotherapy (11), and types of cancer (9). Socio-demographic factors including increasing age (12,9), race e.g., Hispanics (9) and gender e.g., women, played a signi cant role in the incidence of anemia in cancer patients. Besides, number of chemotherapy regimens (13,14), type of chemotherapy (13; 9), chemotherapy dose delay or dose reduction (15), all increased incidence of cancer related anemia (CRA).…”

Section: Introductionmentioning

confidence: 99%

The Prevalence and Associated Factors of Anemia among Breast Cancer Patients Undergoing Chemotherapy: A prospective study

Muthanna

Karuppannan

Abdulrahman

et al. 2022

Preprint

View full text Add to dashboard Cite

Purpose The purpose of this study was to ascertain the prevalence and factors associated with anemia (hemoglobin [Hb] 12 g/dL) in breast cancer patients undergoing chemotherapy. Materials and Methods We conducted a prospective longitudinal study to collect demographic and clinical data on adult breast cancer patients with or without anemia who were admitted to HKL, UMMC, and NCI. The incidence of anemia was determined by detecting whether or not anemia developed during the course of chemotherapy. Mild, moderate, or severe anemia was defined. A chi-square and logistic regression model were used to assess the effect of demographic and clinical factors on the incidence of anemia and multiple logistic regression analysis was used to evaluate the associations of potential risk factors with the presence of CRA. Results The study enrolled a total of 292 breast cancer patients. Anemia occurred at a rate of 41.1% (n = 120). Our findings indicated that clinical factors such as the number of chemotherapy regimens, dose reduction, and type of chemotherapy e.g. docetaxel, as well as demographic covariates such as age and BMI, all contribute to the incidence of anemia in cancer patients. Conclusions According to this study, the prevalence of anemia in breast cancer patients is high. Patients' age, BMI, number of chemotherapy regimens, and docetaxel were risk factors; thus, protocols are needed to identify subgroups of breast cancer likely to benefit from novel management strategies.

show abstract

Outcome and predictors of mortality in patients requiring invasive mechanical ventilation due to acute respiratory failure while undergoing ambulatory chemotherapy for solid cancers

Park

Lim

et al. 2013

Support Care Cancer

View full text Add to dashboard Cite

show abstract

Factors associated with anemia in patients with cancer admitted to an intensive care unit

Cited by 6 publications

References 20 publications

Prevalence and Associated Factors of Anemia among Breast Cancer Patients Undergoing Chemotherapy: A Prospective Study

Prevalence and Associated Factors of Anemia among Breast Cancer Patients Undergoing Chemotherapy: A Prospective Study

The Prevalence and Associated Factors of Anemia among Breast Cancer Patients Undergoing Chemotherapy: A prospective study

Outcome and predictors of mortality in patients requiring invasive mechanical ventilation due to acute respiratory failure while undergoing ambulatory chemotherapy for solid cancers

Contact Info

Product

Resources

About